Area of research
Surgery · Molecular Biology
Research interest
Research interests include Helicobacter pylori-related gastroenterology studies, Pancreatitis Pathology and Treatment, RNA modifications and cancer, and Galectins and Cancer Biology.
<i>Helicobacter pylori</i> infection induces DNA double-strand breaks through the ACVR1/IRF3/POLD1 signaling axis to drive gastric tumorigenesis
Sex-specific effects of gastrointestinal microbiome disruptions on Helicobacter pylori-induced gastric carcinogenesis in INS-GAS mice
Lipidomics and single-cell transcriptomics uncover aberrant lipid metabolism in metaplasia lesions during gastric carcinogenesis
Screening of Traditional Chinese Medicine Compounds Identified the Anti– <i>Helicobacter pylori</i> Effects of Alantolactone, Decursin, and Phillygenin
Unraveling the Role of METTL3 in Helicobacter pylori-induced gastritis via m6A-CXCL1/NF-κB modulation
Single-cell transcriptomic profiling uncovers cellular complexity and microenvironment in gastric tumorigenesis associated with Helicobacter pylori
Metal‐Organic Framework Based Mucoadhesive Nanodrugs for Multifunction <i>Helicobacter Pylori</i> Targeted Eradication, Inflammation Regulation and Gut Flora Protection
Macrophage biology in the pathogenesis of <i>Helicobacter pylori</i> infection
The Protective Role of DDIT4 in Helicobacter pylori-induced Gastric Metaplasia Through Metabolic Regulation of Ferroptosis
Genome-wide DNA methylation profiling reveals a novel hypermethylated biomarker PRKCB in gastric cancer
Clinical characteristics and risk factors of organ failure and death in necrotizing pancreatitis
Pancreatic Organoids: A Frontier Method for Investigating Pancreatic-Related Diseases
Optimization of vonoprazan‐amoxicillin dual therapy for eradicating <i>Helicobacter pylori</i>infection in China: A prospective, randomized clinical pilot study
Convergent dysbiosis of gastric mucosa and fluid microbiome during stomach carcinogenesis
Probiotics mitigate Helicobacter pylori‐induced gastric inflammation and premalignant lesions in INS‐GAS mice with the modulation of gastrointestinal microbiota
Helicobacter pylori infection activates Wnt/β-catenin pathway to promote the occurrence of gastritis by upregulating ASCL1 and AQP5
Analysis of oral microbiota alterations induced by <i>Helicobacter pylori</i> infection and vonoprazan‐amoxicillin dual therapy for <i>Helicobacter pylori</i> eradication
Helicobacter pylori infection worsens impaired glucose regulation in high-fat diet mice in association with an altered gut microbiome and metabolome
MiR‐155 promotes colitis‐associated intestinal fibrosis by targeting HBP1/Wnt/β‐catenin signalling pathway
Activation of Aquaporin 5 by carcinogenic <i>Helicobacter pylori</i> infection promotes epithelial‐mesenchymal transition via the MEK/ERK pathway
<i>Helicobacter pylori</i> induces epithelial‑mesenchymal transition in gastric carcinogenesis via the AKT/GSK3β signaling pathway
Upregulation of oncogene Activin A receptor type I by <i>Helicobacter pylori</i> infection promotes gastric intestinal metaplasia via regulating CDX2
MiR155 Disrupts the Intestinal Barrier by Inducing Intestinal Inflammation and Altering the Intestinal Microecology in Severe Acute Pancreatitis
Discovery and Validation of Novel Methylation Markers in Helicobacter pylori-Associated Gastric Cancer
The NF-κB Signaling Pathway, the Microbiota, and Gastrointestinal Tumorigenesis: Recent Advances
The interplay between the gut microbiota and NLRP3 activation affects the severity of acute pancreatitis in mice
Inhibition of autophagy aggravates DNA damage response and gastric tumorigenesis via Rad51 ubiquitination in response to <i>H. pylori</i> infection
Progression to recurrent acute pancreatitis after a first attack of acute pancreatitis in adults
Integrative Analysis of Differential lncRNA/mRNA Expression Profiling in Helicobacter pylori Infection-Associated Gastric Carcinogenesis
<p>The Clinical Characteristics of Acute Pancreatitis in Gerontal Patients: A Retrospective Study</p>